Research Coverage of Japanese Listed Companies, Shared Research Inc

Shared Research

Research Coverage of Japanese Listed Companies

Shared Research Inc

Pioneering research coverage of Japanese listed companies. Now customizable and interactive for global institutional investors. Corporate access reimagined.

Equity Bottom-Up

<ul><li>FY03/25 sales increased 29.3% YoY, with Electronics segment sales at JPY21.5bn (+36.6% YoY) and Medical and Pharmaceuticals at JPY8.3bn (+12.6% YoY).</li><li>Operating profit grew 83.2% YoY, driven by yen depreciation and increased sales of high value-added white dry films.</li><li>Full-year FY03/25 earnings forecasts revised: Sales JPY116.1bn (+10.8% YoY), Operating profit JPY20.6bn (+13.2% YoY), Net income JPY13.8bn (+59.5% YoY).</li></ul>

FY03/25 sales increased 29.3% YoY, with Electronics segment sales at JPY21.5bn (+36.6% YoY) and Medical and Pharmaceuticals at JPY8.3bn (+12.6% YoY).Operating profit grew 83.2% YoY, driven by yen depreciation and increased sales of high value-added white dry films.Full-year FY03/25 earnings forecasts revised: Sales JPY116.1bn (+10.8% YoY), Operating profit JPY20.6bn (+13.2% YoY), Net income JPY13.8bn (+59.5% YoY).

Taiyo Holdings (4626 JP): Q1 FY03/25 flash update

Japan

TAIYO HOLDINGS CO., LTD. manufactures and sells resist inks for printed circuit boards.  The Company markets the products overseas through its sales and manufacturing subsidiaries in US, Taiwan, Korea, Singapore, and China.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Taiyo Holdings (4626 JP): Q1 FY03/25 flash update

FY03/25 sales increased 29.3% YoY, with Electronics segment sales at JPY21.5bn (+36.6% YoY) and Medical and Pharmaceuticals at JPY8.3bn (+12.6%...

Shared Research